Banka Bioloo

  • Market Cap: Micro Cap
  • Industry: Industrial Manufacturing
  • ISIN: INE862Y01015
  • NSEID: BANKA
  • BSEID:
INR
90.09
-1.74 (-1.89%)
BSENSE

Jun 25, 03:30 PM

BSE+NSE Vol: 5348

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

5.35 k (36.02%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

52.07%

Why is Banka Bioloo Ltd falling/rising?

28-Jun-2026

As of 27-Jun, Banka Bioloo Ltd's stock price is at 90.09, down 1.89%, but has risen 7.71% over the past month and 34.62% year-to-date. Strong financial results and consistent outperformance of the market suggest potential for recovery despite the current decline.

As of 27-Jun, Banka Bioloo Ltd's stock price is currently at 90.09, reflecting a decrease of 1.74, or 1.89%. This decline can be attributed to its performance today, where it underperformed the sector by 1.41%. Despite this short-term drop, the stock has shown strong performance over the past month, with a rise of 7.71%, and a significant year-to-date increase of 34.62%. <BR><BR>The company has reported positive financial results, including the highest quarterly net sales at Rs 17.67 crore and a substantial increase in profits, which have risen by 107.7% over the past year. This indicates a strong underlying business performance, contributing to a favorable valuation compared to its peers. The stock is trading at a discount relative to historical valuations, which may attract investors in the long run.<BR><BR>Moreover, Banka Bioloo has consistently outperformed the broader market, generating a return of 25.18% over the past year while the market has seen negative returns. The stock is also trading above its moving averages, suggesting a generally positive trend despite the current decline. Overall, while the stock is experiencing a temporary fall, its strong fundamentals and market-beating performance indicate potential for recovery and growth in the future.

View full answer

Should I buy, sell or hold Banka Bioloo Ltd?

16-Jun-2026

What does Banka Bioloo do?

11-Jun-2026

Banka Bioloo Ltd specializes in sanitation infrastructure and waste treatment solutions, operating as a Micro Cap company with a market cap of INR 97 Cr. As of March 2026, it reported net sales of 18 Cr and a net profit of 2 Cr.

Overview: <BR>Banka Bioloo Ltd provides sanitation infrastructure and hygienic solutions for human waste treatment and disposal, operating within the Industrial Manufacturing sector and classified as a Micro Cap company.<BR><BR>History: <BR>Banka Bioloo Ltd was incorporated as a Private Limited Company on August 31, 2012, and later changed its status to a Public Limited Company on November 15, 2017. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 18 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 2 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 97 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 147.00 <BR>Industry P/E: 15 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.99 <BR>Return on Equity: -13.55% <BR>Price to Book: 3.08 <BR><BR>Contact Details: <BR>Address: Plot No.11-4-651 A-109 Express, Apartment Lakdi Ka Pool Hyderabad Telangana : 500004 <BR>Tel: 91-40-29801495 <BR>Email: info@bankabio.com <BR>Website: http://www.bankabio.com

View full answer

How big is Banka Bioloo?

11-Jun-2026

As of 10th June, Banka Bioloo Ltd has a market capitalization of 97.00 Cr, with Net Sales of 57.08 Cr and a Net Profit of 0.36 Cr reported in the latest four quarters. Shareholder's Funds are 31.51 Cr and Total Assets amount to 82.16 Cr as of March 2025.

As of 10th June, Banka Bioloo Ltd has a market capitalization of 97.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Banka Bioloo reported Net Sales of 57.08 Cr and a Net Profit of 0.36 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 31.51 Cr and Total Assets of 82.16 Cr.

View full answer

Who are in the management team of Banka Bioloo?

11-Jun-2026

The management team of Banka Bioloo includes Sanjay Banka (Chairman, Executive Director & CEO), Namita Banka (Executive Director, Managing Director & Promoter), and several other executive and independent directors responsible for the company's operations and strategy.

The management team of Banka Bioloo includes the following members:<BR><BR>1. **Sanjay Banka** - Chairman, Executive Director & CEO<BR>2. **Namita Banka** - Executive Director, Managing Director & Promoter<BR>3. **Vishal Murarka** - Executive Director & CEO<BR>4. **Akhilesh Kumar Tripathi** - Executive Director<BR>5. **T V Rama Krishna** - Executive Director & CFO<BR>6. **Sanjay Kumar Gangwar** - Independent Non-Executive Director<BR>7. **Kamalesh Sekhar** - Independent Non-Executive Director<BR>8. **Basava Raju Dumpala** - Independent Non-Executive Director<BR>9. **Aparjit Agarwal** - Independent Non-Executive Director<BR>10. **Anil Sharma** - Independent Non-Executive Director<BR><BR>This team is responsible for overseeing the operations and strategic direction of the company.

View full answer

Who are the peers of the Banka Bioloo?

11-Jun-2026

Banka Bioloo's peers include Holmarc Opto, Emkay Taps & Cut, Womancart, and others, with varying management risks and growth rates. Banka Bioloo has the highest 1-year return at 22.93%, significantly outperforming its peers.

Peers: The peers of Banka Bioloo are Holmarc Opto, Emkay Taps & Cut, Womancart, Lippi Systems, Rapicut Carbides, Shri Balaji, Galaxy Agrico, Meera Industries, Cenlub Industrie, and ITL Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shri Balaji, while Average management risk is found at Holmarc Opto, Emkay Taps & Cut, Womancart, Meera Industries, and Cenlub Industrie, and the rest. Below Average management risk is present at Banka Bioloo, Lippi Systems, Rapicut Carbides, and Galaxy Agrico. Growth is Excellent at Womancart, Average at Holmarc Opto, Emkay Taps & Cut, Meera Industries, and Cenlub Industrie, and the rest, while Below Average growth is seen at Banka Bioloo, Lippi Systems, Rapicut Carbides, and Galaxy Agrico. Capital Structure is Excellent at Emkay Taps & Cut and Average at Meera Industries and Cenlub Industrie, while Good is noted at Holmarc Opto and Shri Balaji, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Banka Bioloo at 22.93%, while the lowest is Emkay Taps & Cut at -60.38%. Banka Bioloo's return is significantly higher than its peers. Additionally, Womancart, Lippi Systems, Rapicut Carbides, Shri Balaji, Galaxy Agrico, and Meera Industries all have negative six-month returns.

View full answer

Are Banka Bioloo Ltd latest results good or bad?

13-Feb-2026

Banka Bioloo Ltd's latest results show record revenue growth but continued net losses, marking the seventh consecutive quarter of negative earnings. While there are improvements in operating margins, persistent profitability challenges and high leverage indicate a cautious outlook for investors.

Banka Bioloo Ltd's latest results present a mixed picture. On one hand, the company achieved a record revenue of ₹15.26 crores in Q3 FY26, marking a significant 17.29% quarter-on-quarter increase and an 8.69% year-on-year growth. This indicates improving demand for its sanitation solutions and suggests some operational momentum.<BR><BR>However, the company continues to face persistent challenges with profitability. It reported a net loss of ₹0.15 crores for the quarter, although this is an 86.11% improvement from the previous quarter's loss of ₹1.08 crores. Despite this narrowing of losses, it marks the seventh consecutive quarter of negative earnings, raising concerns about its ability to achieve sustainable profitability.<BR><BR>Additionally, the operating margin improved to 9.50%, the highest in recent quarters, but the overall financial health remains precarious, with a low return on equity of 1.94% and significant leverage indicated by a debt-to-EBITDA ratio of 7.90 times. These factors contribute to a challenging outlook for the company.<BR><BR>In summary, while there are positive signs in terms of revenue growth and improved margins, the ongoing losses and structural financial issues suggest that the results are more concerning than encouraging. Investors should be cautious given the company's fundamental challenges.

View full answer

How has been the historical performance of Banka Bioloo?

15-Nov-2025

Banka Bioloo has experienced revenue growth from 30.46 Cr in March 2021 to 54.17 Cr in March 2025, but has faced significant losses, with profit after tax dropping to -8.94 Cr and operating profit turning negative at -2.55 Cr. Total liabilities and assets have increased, while cash flow from operations declined to 0.00 Cr, indicating deteriorating profitability and cash generation.

Answer:<BR>The historical performance of Banka Bioloo shows a fluctuating trend in key financial metrics over the years leading up to March 2025.<BR><BR>Breakdown:<BR>Banka Bioloo's net sales have increased from 30.46 Cr in March 2021 to 54.17 Cr in March 2025, indicating a positive growth trajectory. However, total expenditure has also risen significantly, reaching 57.05 Cr in March 2025, up from 27.05 Cr in March 2021. This has resulted in an operating profit (PBDIT) that turned negative at -2.55 Cr in March 2025, compared to a positive 9.13 Cr in March 2020. The company has faced increasing losses, with profit before tax dropping to -9.15 Cr in March 2025 from a profit of 7.85 Cr in March 2020. Consequently, the profit after tax also fell to -8.94 Cr in March 2025, down from 6.23 Cr in March 2020. The total liabilities have increased from 46.36 Cr in March 2021 to 82.16 Cr in March 2025, while total assets have similarly risen to 82.16 Cr in March 2025 from 46.36 Cr in March 2021. Cash flow from operating activities has been inconsistent, with a notable decline to 0.00 Cr in March 2025, reflecting challenges in generating cash from core operations. Overall, while revenue growth is evident, the company's profitability and cash flow have deteriorated significantly in recent years.

View full answer

Who are the top shareholders of the Banka Bioloo?

17-Jul-2025

The top shareholders of Banka Bioloo include Namita Sanjay Banka with 30.2%, Akhilesh Kumar Tripathi at 3.93%, and individual investors collectively holding 37.82%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of Banka Bioloo include Namita Sanjay Banka, who is the promoter with the highest holding at 30.2%. The highest public shareholder is Akhilesh Kumar Tripathi, holding 3.93%. Additionally, individual investors collectively hold 37.82% of the shares. There are currently no mutual funds or foreign institutional investors (FIIs) holding shares in the company.

View full answer

Is Banka Bioloo overvalued or undervalued?

09-Jun-2025

As of November 18, 2024, Banka Bioloo Ltd. is considered overvalued and risky due to negative financial ratios and significant underperformance compared to its peers and the Sensex.

As of 18 November 2024, the valuation grade for Banka Bioloo Ltd. has moved from fair to risky, indicating a significant deterioration in its financial outlook. The company appears to be overvalued based on several key ratios, including a PE ratio of -8.02, an EV to EBITDA ratio of -34.51, and a ROE of -27.29%. These figures suggest that the company is struggling to generate profits and is facing substantial financial challenges.<BR><BR>In comparison to its peers, Banka Bioloo's valuation metrics are concerning. For instance, while the company has a negative PE ratio, its peer group shows more favorable valuations, which raises questions about its market position. The stock has underperformed significantly against the Sensex, with a year-to-date return of -34.96% compared to the Sensex's 6.25%. Overall, the combination of negative financial ratios and poor stock performance suggests that Banka Bioloo is overvalued in the current market environment.

View full answer

What is the technical trend for Banka Bioloo?

09-Jun-2025

As of June 2, 2025, Banka Bioloo's technical trend is bearish, supported by bearish signals from moving averages, Bollinger Bands, and the KST, despite a mildly bullish weekly MACD.

As of 2 June 2025, the technical trend for Banka Bioloo has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. The weekly MACD is mildly bullish, but the monthly MACD indicates a bearish trend. Both the weekly and monthly Bollinger Bands confirm a bearish outlook. Daily moving averages are also bearish, reinforcing the negative sentiment. The KST shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, while the Dow Theory and OBV both reflect a mildly bearish stance in both time frames. Overall, the combination of these indicators suggests a bearish trend for Banka Bioloo.

View full answer

When is the next results date for Banka Bioloo?

06-Jun-2025

No Upcoming Board Meetings

What is the bonus history of the Banka Bioloo?

06-Jun-2025

Banka Bioloo issued a 3:2 bonus on September 8, 2020, with a record date of September 9, 2020, meaning shareholders received three shares for every two shares held.

Banka Bioloo has a bonus history that includes a 3:2 bonus issue announced with an ex-date of September 8, 2020. The record date for this bonus was September 9, 2020. This means that for every two shares held, shareholders received three shares as part of this bonus issue.

View full answer

Has Banka Bioloo declared dividend?

06-Jun-2025

Banka Bioloo Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 8, 2020. Despite the dividend declaration, the dividend yield is 0%, and total returns have been negative in the short to medium term, though there was a significant positive return of 601.54% over five years.

Banka Bioloo Ltd has declared a 5% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 5%<BR>- Amount per share: 0.5<BR>- Ex-date: 08 Sep 2020<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -40.14%, the dividend return was 0%, resulting in a total return of -40.14%.<BR><BR>In the 1-year period, the price return was -37.97%, the dividend return was 0%, leading to a total return of -37.97%.<BR><BR>In the 2-year period, the price return was -10.66%, the dividend return was 0%, which resulted in a total return of -10.66%.<BR><BR>In the 3-year period, the price return was -11.59%, the dividend return was 0%, culminating in a total return of -11.59%.<BR><BR>In the 4-year period, the price return was -14.44%, the dividend return was 0%, resulting in a total return of -14.44%.<BR><BR>In the 5-year period, the price return was 601.54%, the dividend return was 0%, leading to a total return of 601.54%.<BR><BR>Overall, while Banka Bioloo Ltd has declared a dividend, the dividend yield remains at 0%. The total returns over various periods show significant negative returns in the short to medium term, but a substantial positive return over the five-year period.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a -0.34% CAGR growth in Operating Profits over the last 5 years

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.92 times
  • The company has been able to generate a Return on Equity (avg) of 3.26% signifying low profitability per unit of shareholders funds
2

Positive results in Mar 26

3

With ROCE of 3.4, it has a Attractive valuation with a 1.8 Enterprise value to Capital Employed

4

Majority shareholders : Promoters

 
5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

INR 105 Cr (Micro Cap)

stock-summary
P/E

149.00

stock-summary
Industry P/E

37

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.75

stock-summary
Return on Equity

1.67%

stock-summary
Price to Book

2.54

Revenue and Profits:
Net Sales:
18 Cr
(Quarterly Results - Mar 2026)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
94.66%
0%
94.66%
6 Months
38.83%
0%
38.83%
1 Year
25.18%
0%
25.18%
2 Years
-12.28%
0%
-12.28%
3 Years
30.38%
0%
30.38%
4 Years
40.0%
0%
40.0%
5 Years
31.33%
0%
31.33%

Latest dividend: 0.5 per share ex-dividend date: Sep-08-2020

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Banka Bioloo Gains 1.22%: 3 Key Factors Driving the Week’s Momentum

Announcements stock-summary

Banka BioLoo Limited - Reply to Clarification- Financial results

28-Nov-2019 | Source : NSE

Banka BioLoo LimitedioLoo Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Banka BioLoo Limited - Outcome of Board Meeting

15-Nov-2019 | Source : NSE

Banka BioLoo Limitedf directors in their just concluded Board meeting have inter-alia transacted the following business:

Banka BioLoo Limited - Change in Director(s)

06-Nov-2019 | Source : NSE

Banka BioLoo Limited has informed the Exchange regarding Change in Director(s) of the company.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Banka Bioloo Ltd has declared 5% dividend, ex-date: 08 Sep 20

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Banka Bioloo Ltd has announced 3:2 bonus issue, ex-date: 08 Sep 20

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.38%
EBIT Growth (5y)
-0.34%
EBIT to Interest (avg)
1.04
Debt to EBITDA (avg)
8.44
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.77
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.71%
ROE (avg)
3.26%

Valuation key factors

Factor
Value
P/E Ratio
149
Industry P/E
Price to Book Value
2.49
EV to EBIT
54.55
EV to EBITDA
24.89
EV to Capital Employed
1.85
EV to Sales
2.25
PEG Ratio
1.39
Dividend Yield
NA
ROCE (Latest)
3.39%
ROE (Latest)
1.67%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Namita Sanjay Banka (29.89%)

Highest Public shareholder

Suresh Ramniklal Shah (3.75%)

Individual Investors Holdings

37.83%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 19.07% vs -9.01% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 197.53% vs -575.00% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.67",
          "val2": "14.84",
          "chgp": "19.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.37",
          "val2": "-0.17",
          "chgp": "2,082.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.93",
          "val2": "1.03",
          "chgp": "-9.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.58",
          "val2": "-1.62",
          "chgp": "197.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "19.07%",
          "val2": "-1.15%",
          "chgp": "20.22%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -4.55% vs 28.23% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 81.51% vs -421.43% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "24.15",
          "val2": "25.30",
          "chgp": "-4.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.33",
          "val2": "-2.73",
          "chgp": "112.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.83",
          "val2": "1.73",
          "chgp": "5.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.32",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.08",
          "val2": "-5.84",
          "chgp": "81.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.37%",
          "val2": "-10.79%",
          "chgp": "12.16%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.18% vs 16.77% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 83.15% vs -1,638.10% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.41",
          "val2": "39.34",
          "chgp": "0.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.78",
          "val2": "-2.70",
          "chgp": "165.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.74",
          "val2": "2.74",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.32",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1.23",
          "val2": "-7.30",
          "chgp": "83.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.52%",
          "val2": "-6.86%",
          "chgp": "11.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 5.39% vs 8.34% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 103.92% vs -1,272.31% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "57.09",
          "val2": "54.17",
          "chgp": "5.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.19",
          "val2": "-2.88",
          "chgp": "280.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.69",
          "val2": "3.76",
          "chgp": "-1.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.30",
          "val2": "-0.32",
          "chgp": "6.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.35",
          "val2": "-8.92",
          "chgp": "103.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.09%",
          "val2": "-5.32%",
          "chgp": "14.41%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
17.67
14.84
19.07%
Operating Profit (PBDIT) excl Other Income
3.37
-0.17
2,082.35%
Interest
0.93
1.03
-9.71%
Exceptional Items
-0.30
0.00
Consolidate Net Profit
1.58
-1.62
197.53%
Operating Profit Margin (Excl OI)
19.07%
-1.15%
20.22%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 19.07% vs -9.01% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 197.53% vs -575.00% in Mar 2025

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
24.15
25.30
-4.55%
Operating Profit (PBDIT) excl Other Income
0.33
-2.73
112.09%
Interest
1.83
1.73
5.78%
Exceptional Items
0.00
-0.32
100.00%
Consolidate Net Profit
-1.08
-5.84
81.51%
Operating Profit Margin (Excl OI)
1.37%
-10.79%
12.16%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -4.55% vs 28.23% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 81.51% vs -421.43% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
39.41
39.34
0.18%
Operating Profit (PBDIT) excl Other Income
1.78
-2.70
165.93%
Interest
2.74
2.74
Exceptional Items
0.00
-0.32
100.00%
Consolidate Net Profit
-1.23
-7.30
83.15%
Operating Profit Margin (Excl OI)
4.52%
-6.86%
11.38%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 0.18% vs 16.77% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 83.15% vs -1,638.10% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
57.09
54.17
5.39%
Operating Profit (PBDIT) excl Other Income
5.19
-2.88
280.21%
Interest
3.69
3.76
-1.86%
Exceptional Items
-0.30
-0.32
6.25%
Consolidate Net Profit
0.35
-8.92
103.92%
Operating Profit Margin (Excl OI)
9.09%
-5.32%
14.41%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 5.39% vs 8.34% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 103.92% vs -1,272.31% in Mar 2025

stock-summaryCompany CV
About Banka Bioloo Ltd stock-summary
stock-summary
Banka Bioloo Ltd
Micro Cap
Industrial Manufacturing
Banka BioLoo Limited was incorporated as a Private Limited Company with the name "Banka BioLoo Private Limited" on August 31, 2012. The Company status changed to a Public Limited Company and the name of the Company was changed to Banka BioLoo Limited on November 15, 2017. The Company was incorporated to provide sanitation infrastructure and hygienic solutions for human waste treatment and disposal.
Company Coordinates stock-summary
Company Details
Plot No.11-4-651 A-109 Express, Apartment Lakdi Ka Pool Hyderabad Telangana : 500004
stock-summary
Tel: 91-40-29801495
stock-summary
info@bankabio.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai